Inventor · disambiguated record
Ennio Antonio Chiocca
Also filed as: CHIOCCA ENNIO ANTONIO
8 granted patents·3 pending applications·133 citations·filing 2000–2025
80Inventor score
Top patents by PatentIndex Score
11 records- 0196US6511967B1Use of an internalizing transferrin receptor to image transgene expressionGEN HOSPITAL CORP·Filed 2000·Granted Jan 28, 2003·132 cites·27 claims
- 0278US12385067B2Compositions and therapeutic methods of microRNA gene deliveryBRIGHAM & WOMENS HOSPITAL INC·Filed 2024·Granted Aug 12, 2025·0 cites·35 claims
- 0375US10806761B2Oncolytic HSV1 vector and methods of useBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted Oct 20, 2020·1 cites·9 claims
- 0473US2025340904A1Compositions and therapeutic methods of microrna gene deliveryBRIGHAM & WOMENS HOSPITAL INC·Filed 2025·Application pending·0 cites
- 0569US10610554B2Oncolytic expression vector comprising a nucleic acid comprising a nucleotide sequence encoding GADD34BRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Granted Apr 7, 2020·0 cites·7 claims
- 0663US11946064B2Compositions and therapeutic methods of microRNA gene deliveryBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Granted Apr 2, 2024·0 cites·24 claims
- 0758US2023374508A1Compositions and Methods Targeting circ2082 for the Treatment of CancerBRIGHAM & WOMENS HOSPITAL INC·Filed 2021·Application pending·0 cites
- 0857US10232002B1Oncolytic HSV1 vectors and methods of using the sameBRIGHAM & WOMENS HOSPITAL INC·Filed 2013·Granted Mar 19, 2019·0 cites·6 claims
- 0957US2024167098A1Methods for predicting treatment outcome to checkpoint inhibitors in cancerBRIGHAM & WOMENS HOSPITAL INC·Filed 2022·Application pending·0 cites
- 1054US11117977B2Anti-fibulin-3 antibodies and uses thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Granted Sep 14, 2021·0 cites·15 claims
- 1138US10538591B2Anti-fibulin-3 antibodies and uses thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Granted Jan 21, 2020·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Ennio Antonio Chiocca files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →